-
1
المؤلفون: Cécile Pagès, Raphaël Porcher, Majdi Jebali, Clara Allayous, Nika Madjlessi, R. Amode, A. Kowal, Céleste Lebbé, Manuelle Viguier, Nicole Basset Seguin, J. Roux, Barouyr Baroudjian, Martine Bagot
المصدر: Melanoma Research. 27:110-115
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Programmed Cell Death 1 Receptor, Ipilimumab, Dermatology, Pembrolizumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Group B, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Humans, Medicine, 030212 general & internal medicine, Stage (cooking), Adverse effect, Melanoma, Aged, Neoplasm Staging, business.industry, Incidence (epidemiology), Antibodies, Monoclonal, Middle Aged, Surgery, Survival Rate, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Retreatment, Female, Observational study, Immunotherapy, business, Follow-Up Studies, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8128a4b495ae83e78a6b37d9d3b06400Test
https://doi.org/10.1097/cmr.0000000000000313Test -
2
المؤلفون: Ib Jarle Christensen, Julia S. Johansen, Lars Bastholt, Stefan Suciu, Henrik Schmidt, Merete Krogh, Marna G. Bouwhuis, Johan Hansson, Alexander M.M. Eggermont, Peter Nørgaard
المساهمون: Emergency Medicine, Epidemiology
المصدر: Krogh, M, Christensen, I, Bouwhuis, M, Johansen, J S, Nørgaard, P, Schmidt, H, Hansson, J, Suciu, S, Eggermont, A M M, Bastholt, L & Nordic Melanoma Group and EORTC Melanoma Group 2016, ' Prognostic and predictive value of YKL-40 in stage IIB-III melanoma ', Melanoma Research, vol. 26, no. 4, pp. 367-76 . https://doi.org/10.1097/CMR.0000000000000237Test
Krogh, M, Christensen, I, Bouwhuis, M, Johansen, J S, Nørgaard, P, Schmidt, H, Hansson, J, Suciu, S, Eggermont, A M M, Bastholt, L & Nordic Melanoma Group and EORTC Melanoma Group 2016, ' Prognostic and predictive value of YKL-40 in stage IIB-III melanoma ', Melanoma Research, vol. 26, no. 4, pp. 367-376 . https://doi.org/10.1097/CMR.0000000000000237Test
Melanoma Research, 26(4), 367-376. Lippincott Williams & Wilkinsمصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, musculoskeletal diseases, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Adolescent, Alpha interferon, Dermatology, Interferon alpha-2, CHI3L1, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Biomarkers, Tumor, medicine, Journal Article, Humans, Chitinase-3-Like Protein 1, Prospective Studies, Prospective cohort study, Melanoma, Lymph node, Aged, Neoplasm Staging, Univariate analysis, business.industry, Hazard ratio, Interferon-alpha, Cancer, Middle Aged, Prognosis, medicine.disease, Recombinant Proteins, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c2b4a125a416d8f3a3851aa358d182Test
https://doi.org/10.1097/cmr.0000000000000237Test